CURRENT ISSUE

Genetic Engineering " Biotechnology News - Current Issue

(view larger image)

SUBSCRIBE

AD LINK

Visit GEN on Twitter!

GEN News Highlights

  • Print
  • Share
  • More GEN News Highlights

Jul 11 2006, 3:49 PM EST

Lion Biosciences to Take Over Axaron Bioscience through Acquisition of Sygnis

GEN News Highlights

LION bioscience signed a contract acquiring Sygnis Bioscience. After that deal goes through, Axaron bioscience will assign its entire operating business to Sygnis Bioscience. Axaron Bioscience, founded in 1997, develops therapies to treat neurodegenerative diseases. AX200, a product for the treatment of strokes, is the company’s most advanced compound and is currently being tested in a Phase IIa clinical trial. Lion has been restructuring its operations since the end of 2004.
  • Print
  • Share
  • More GEN News Highlights

Comment on this News:

Name:
Title:
Comment:

HELP US FIGHT SPAMMING ROBOTS by answering the following simple question. It will verify you as a legitimate user wishing to post a comment. Thank you for your cooperation.

CAREER CENTER

Visit the GEN Career Center

for the latest biotech employment opportunities.
Start your search HERE!

visit the Career Center

WEBINARS

view all webinars

GEN and Scintellix bring you the Cryptogram Challenge: ELISA REDUX!

PODCASTS

INTERVIEW: (BIO) BANKING IN LUXEMBOURG - Interview with Robert Hewitt, Ph.D., CEO, Integrated Biobank of Luxembourg, and European Editor, Biopreservation and Biobanking (published by Mary Ann Liebert, Inc.) ...MORE

MOST POPULAR

News

Articles

Blogs